Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses 7.96 B8.42 B 31.79 B Research & development —— — Operating income 4.98 B6.84 B 21.02 B Non-Operating Income, Total -604 M-524 M -2.27 B Interest expense, net of interest capitalized 611 M583 M 2.42 B Non-Operating Income, excl. Interest Expenses -1.22 B-1.11 B -4.69 B Unusual income/expense —— — Pretax income 4.38 B6.32 B 18.75 B Equity in earnings —— — Taxes 1.09 B1.55 B 4.52 B Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 3.29 B4.77 B 14.23 B Discontinued operations —— — Net income 3.29 B4.77 B 14.23 B Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 3.29 B4.77 B 14.23 B Basic earnings per share (Basic EPS) 3.314.79 14.31 Diluted earnings per share (Diluted EPS) 3.34.79 14.29 Average basic shares outstanding 994 M994 M — Diluted shares outstanding 996 M996 M — EBITDA 5.89 B7.77 B 24.66 B EBIT 4.98 B6.84 B 21.02 B Cost of revenue 27.98 B31.75 B 113 B Other cost of goods sold —— — Depreciation & amortization (cash flow) 910 M929 M 3.63 B